<t>IKK</t> inhibition reduced growth of V2D1 tumors (A) Blood from wt or DBA1- Rag1 −/− -mice was analyzed for CD3 and B220. (B) V2D1-cells (1 × 10 6 ) were injected subcutaneously into the flanks of DBA/1- Rag1 −/− -mice and tumor area was assessed for 6 weeks using a Mitutoyo Quick Mini caliper. Growing tumors were either treated with DMSO/PBS (blue line) or with IKK-inhibitor <t>VII</t> (red line) (25 μM). [Data represent the mean SD of 10 mice with tumors ( p